Cargando…
Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease
It has been 200 years since Parkinson disease (PD) was described by Dr. Parkinson in 1817. The disease is the second most common neurodegenerative disease characterized by a progressive loss of dopaminergic neurons in the substantia nigra pars compacta. Although the pathogenesis of PD is still unkno...
Autores principales: | Zeng, Xian-Si, Geng, Wen-Shuo, Jia, Jin-Jing, Chen, Lei, Zhang, Peng-Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5913322/ https://www.ncbi.nlm.nih.gov/pubmed/29719505 http://dx.doi.org/10.3389/fnagi.2018.00109 |
Ejemplares similares
-
Molecular and Cellular Basis of Neurodegeneration in Alzheimer’s Disease
por: Jeong, Sangyun
Publicado: (2017) -
The Biochemical and Cellular Basis for Nutraceutical Strategies to Attenuate Neurodegeneration in Parkinson’s Disease
por: Mazzio, Elizabeth A., et al.
Publicado: (2011) -
The Ageing Brain: Molecular and Cellular Basis of Neurodegeneration
por: Azam, Shofiul, et al.
Publicado: (2021) -
Neurotoxin-Induced Animal Models of Parkinson Disease: Pathogenic Mechanism and Assessment
por: Zeng, Xian-Si, et al.
Publicado: (2018) -
Potential roles of oxidative distress on neurodegeneration in Parkinson's disease with neuropsychiatric symptoms
por: Li, Dan-ning, et al.
Publicado: (2022)